The epidermal growth factor receptor (EGFR) was one of the inverse expressed targets in this pathway, and several studies demonstrated that EGFR inhibitors improve pathological and behavioural conditions in AD [70,71]. The gene discussed is EGFR; the disease is Alzheimer disease.